nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A4—Crohn's disease	0.514	0.571	CbGaD
Tiotropium—SLC22A5—Crohn's disease	0.387	0.429	CbGaD
Tiotropium—Oropharyngeal candidiasis—Prednisone—Crohn's disease	0.0073	0.118	CcSEcCtD
Tiotropium—Oral candidiasis—Mercaptopurine—Crohn's disease	0.00241	0.039	CcSEcCtD
Tiotropium—Candida infection—Mercaptopurine—Crohn's disease	0.00146	0.0236	CcSEcCtD
Tiotropium—Mouth ulceration—Mercaptopurine—Crohn's disease	0.00139	0.0224	CcSEcCtD
Tiotropium—Oral candidiasis—Mesalazine—Crohn's disease	0.00131	0.0212	CcSEcCtD
Tiotropium—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.00123	0.0199	CcSEcCtD
Tiotropium—Intestinal obstruction—Mesalazine—Crohn's disease	0.00122	0.0197	CcSEcCtD
Tiotropium—Laryngeal pain—Mesalazine—Crohn's disease	0.00122	0.0197	CcSEcCtD
Tiotropium—Herpes zoster—Azathioprine—Crohn's disease	0.00121	0.0196	CcSEcCtD
Tiotropium—Intraocular pressure increased—Prednisone—Crohn's disease	0.001	0.0162	CcSEcCtD
Tiotropium—Stomatitis—Mercaptopurine—Crohn's disease	0.000836	0.0135	CcSEcCtD
Tiotropium—Influenza like illness—Mesalazine—Crohn's disease	0.000808	0.013	CcSEcCtD
Tiotropium—Candida infection—Mesalazine—Crohn's disease	0.000794	0.0128	CcSEcCtD
Tiotropium—Mouth ulceration—Mesalazine—Crohn's disease	0.000752	0.0121	CcSEcCtD
Tiotropium—Immune system disorder—Mercaptopurine—Crohn's disease	0.000695	0.0112	CcSEcCtD
Tiotropium—Malnutrition—Mercaptopurine—Crohn's disease	0.00067	0.0108	CcSEcCtD
Tiotropium—Arthritis—Mesalazine—Crohn's disease	0.000621	0.01	CcSEcCtD
Tiotropium—Glaucoma—Prednisone—Crohn's disease	0.000584	0.00944	CcSEcCtD
Tiotropium—Arthralgia—Mercaptopurine—Crohn's disease	0.00057	0.00921	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000566	0.00915	CcSEcCtD
Tiotropium—Dry skin—Mesalazine—Crohn's disease	0.000553	0.00894	CcSEcCtD
Tiotropium—Oedema—Mercaptopurine—Crohn's disease	0.000547	0.00883	CcSEcCtD
Tiotropium—Skin disorder—Mercaptopurine—Crohn's disease	0.000531	0.00858	CcSEcCtD
Tiotropium—Dysphagia—Mesalazine—Crohn's disease	0.000522	0.00843	CcSEcCtD
Tiotropium—Angina pectoris—Mesalazine—Crohn's disease	0.000508	0.00821	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000498	0.00805	CcSEcCtD
Tiotropium—Dysuria—Mesalazine—Crohn's disease	0.000488	0.00788	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000485	0.00783	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000472	0.00763	CcSEcCtD
Tiotropium—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000465	0.00752	CcSEcCtD
Tiotropium—Cataract—Prednisone—Crohn's disease	0.000462	0.00747	CcSEcCtD
Tiotropium—Renal failure—Mesalazine—Crohn's disease	0.000457	0.00739	CcSEcCtD
Tiotropium—Stomatitis—Mesalazine—Crohn's disease	0.000454	0.00733	CcSEcCtD
Tiotropium—Urinary tract infection—Mesalazine—Crohn's disease	0.000452	0.00731	CcSEcCtD
Tiotropium—Epistaxis—Mesalazine—Crohn's disease	0.000439	0.00709	CcSEcCtD
Tiotropium—Sinusitis—Mesalazine—Crohn's disease	0.000436	0.00705	CcSEcCtD
Tiotropium—Rhinitis—Mesalazine—Crohn's disease	0.000419	0.00676	CcSEcCtD
Tiotropium—Pharyngitis—Mesalazine—Crohn's disease	0.000415	0.0067	CcSEcCtD
Tiotropium—Immune system disorder—Azathioprine—Crohn's disease	0.000414	0.00669	CcSEcCtD
Tiotropium—Mediastinal disorder—Azathioprine—Crohn's disease	0.000413	0.00668	CcSEcCtD
Tiotropium—Urinary tract disorder—Mesalazine—Crohn's disease	0.000412	0.00666	CcSEcCtD
Tiotropium—Oedema peripheral—Mesalazine—Crohn's disease	0.000411	0.00665	CcSEcCtD
Tiotropium—Connective tissue disorder—Mesalazine—Crohn's disease	0.00041	0.00663	CcSEcCtD
Tiotropium—Arrhythmia—Azathioprine—Crohn's disease	0.00041	0.00662	CcSEcCtD
Tiotropium—Urethral disorder—Mesalazine—Crohn's disease	0.000409	0.00661	CcSEcCtD
Tiotropium—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000403	0.00651	CcSEcCtD
Tiotropium—Eye disorder—Mesalazine—Crohn's disease	0.00039	0.00631	CcSEcCtD
Tiotropium—Angiopathy—Mesalazine—Crohn's disease	0.000379	0.00612	CcSEcCtD
Tiotropium—Immune system disorder—Mesalazine—Crohn's disease	0.000377	0.00609	CcSEcCtD
Tiotropium—Mediastinal disorder—Mesalazine—Crohn's disease	0.000376	0.00608	CcSEcCtD
Tiotropium—Mental disorder—Mesalazine—Crohn's disease	0.000366	0.00591	CcSEcCtD
Tiotropium—Back pain—Mesalazine—Crohn's disease	0.000352	0.00568	CcSEcCtD
Tiotropium—Vomiting—Mercaptopurine—Crohn's disease	0.000348	0.00562	CcSEcCtD
Tiotropium—Rash—Mercaptopurine—Crohn's disease	0.000345	0.00557	CcSEcCtD
Tiotropium—Dermatitis—Mercaptopurine—Crohn's disease	0.000344	0.00556	CcSEcCtD
Tiotropium—Vision blurred—Mesalazine—Crohn's disease	0.000343	0.00554	CcSEcCtD
Tiotropium—Myalgia—Azathioprine—Crohn's disease	0.00034	0.00549	CcSEcCtD
Tiotropium—Arthralgia—Azathioprine—Crohn's disease	0.00034	0.00549	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000337	0.00545	CcSEcCtD
Tiotropium—Angioedema—Mesalazine—Crohn's disease	0.000332	0.00537	CcSEcCtD
Tiotropium—Syncope—Mesalazine—Crohn's disease	0.000326	0.00527	CcSEcCtD
Tiotropium—Nausea—Mercaptopurine—Crohn's disease	0.000325	0.00525	CcSEcCtD
Tiotropium—Infection—Azathioprine—Crohn's disease	0.000324	0.00523	CcSEcCtD
Tiotropium—Palpitations—Mesalazine—Crohn's disease	0.000321	0.00519	CcSEcCtD
Tiotropium—Loss of consciousness—Mesalazine—Crohn's disease	0.00032	0.00516	CcSEcCtD
Tiotropium—Cough—Mesalazine—Crohn's disease	0.000317	0.00513	CcSEcCtD
Tiotropium—Skin disorder—Azathioprine—Crohn's disease	0.000316	0.00511	CcSEcCtD
Tiotropium—Hypertension—Mesalazine—Crohn's disease	0.000314	0.00507	CcSEcCtD
Tiotropium—Myalgia—Mesalazine—Crohn's disease	0.00031	0.005	CcSEcCtD
Tiotropium—Chest pain—Mesalazine—Crohn's disease	0.00031	0.005	CcSEcCtD
Tiotropium—Arthralgia—Mesalazine—Crohn's disease	0.00031	0.005	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000307	0.00497	CcSEcCtD
Tiotropium—Dry mouth—Mesalazine—Crohn's disease	0.000303	0.00489	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000297	0.00479	CcSEcCtD
Tiotropium—Oedema—Mesalazine—Crohn's disease	0.000297	0.00479	CcSEcCtD
Tiotropium—Infection—Mesalazine—Crohn's disease	0.000295	0.00476	CcSEcCtD
Tiotropium—Dry skin—Prednisone—Crohn's disease	0.000293	0.00473	CcSEcCtD
Tiotropium—Shock—Mesalazine—Crohn's disease	0.000292	0.00472	CcSEcCtD
Tiotropium—Nervous system disorder—Mesalazine—Crohn's disease	0.000291	0.0047	CcSEcCtD
Tiotropium—Tachycardia—Mesalazine—Crohn's disease	0.00029	0.00468	CcSEcCtD
Tiotropium—Skin disorder—Mesalazine—Crohn's disease	0.000288	0.00466	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000281	0.00454	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00027	0.00437	CcSEcCtD
Tiotropium—Insomnia—Mesalazine—Crohn's disease	0.000268	0.00434	CcSEcCtD
Tiotropium—Paraesthesia—Mesalazine—Crohn's disease	0.000266	0.0043	CcSEcCtD
Tiotropium—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000266	0.0043	CcSEcCtD
Tiotropium—Dyspepsia—Mesalazine—Crohn's disease	0.000261	0.00422	CcSEcCtD
Tiotropium—Abdominal pain—Azathioprine—Crohn's disease	0.000258	0.00416	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000256	0.00414	CcSEcCtD
Tiotropium—Constipation—Mesalazine—Crohn's disease	0.000254	0.0041	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—Crohn's disease	0.000249	0.00402	CcSEcCtD
Tiotropium—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000243	0.00392	CcSEcCtD
Tiotropium—Hypersensitivity—Azathioprine—Crohn's disease	0.00024	0.00388	CcSEcCtD
Tiotropium—Urticaria—Mesalazine—Crohn's disease	0.000236	0.00381	CcSEcCtD
Tiotropium—Abdominal pain—Mesalazine—Crohn's disease	0.000235	0.00379	CcSEcCtD
Tiotropium—Hypersensitivity—Mesalazine—Crohn's disease	0.000219	0.00353	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—Crohn's disease	0.000217	0.00351	CcSEcCtD
Tiotropium—Dizziness—Azathioprine—Crohn's disease	0.000215	0.00348	CcSEcCtD
Tiotropium—Pruritus—Mesalazine—Crohn's disease	0.00021	0.00339	CcSEcCtD
Tiotropium—Vomiting—Azathioprine—Crohn's disease	0.000207	0.00335	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—Crohn's disease	0.000207	0.00334	CcSEcCtD
Tiotropium—Rash—Azathioprine—Crohn's disease	0.000205	0.00332	CcSEcCtD
Tiotropium—Dermatitis—Azathioprine—Crohn's disease	0.000205	0.00332	CcSEcCtD
Tiotropium—Headache—Azathioprine—Crohn's disease	0.000204	0.0033	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—Crohn's disease	0.0002	0.00324	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—Crohn's disease	0.0002	0.00322	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—Crohn's disease	0.000197	0.00319	CcSEcCtD
Tiotropium—Dizziness—Mesalazine—Crohn's disease	0.000196	0.00317	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—Crohn's disease	0.000194	0.00313	CcSEcCtD
Tiotropium—Nausea—Azathioprine—Crohn's disease	0.000193	0.00313	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—Crohn's disease	0.000192	0.00311	CcSEcCtD
Tiotropium—Vomiting—Mesalazine—Crohn's disease	0.000189	0.00305	CcSEcCtD
Tiotropium—Rash—Mesalazine—Crohn's disease	0.000187	0.00302	CcSEcCtD
Tiotropium—Dermatitis—Mesalazine—Crohn's disease	0.000187	0.00302	CcSEcCtD
Tiotropium—Headache—Mesalazine—Crohn's disease	0.000186	0.003	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—Crohn's disease	0.000181	0.00293	CcSEcCtD
Tiotropium—Nausea—Mesalazine—Crohn's disease	0.000176	0.00285	CcSEcCtD
Tiotropium—Angioedema—Prednisone—Crohn's disease	0.000176	0.00284	CcSEcCtD
Tiotropium—Syncope—Prednisone—Crohn's disease	0.000173	0.00279	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—Crohn's disease	0.000169	0.00273	CcSEcCtD
Tiotropium—Hypertension—Prednisone—Crohn's disease	0.000166	0.00268	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—Crohn's disease	0.000164	0.00265	CcSEcCtD
Tiotropium—Myalgia—Prednisone—Crohn's disease	0.000164	0.00265	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000163	0.00263	CcSEcCtD
Tiotropium—Oedema—Prednisone—Crohn's disease	0.000157	0.00254	CcSEcCtD
Tiotropium—Infection—Prednisone—Crohn's disease	0.000156	0.00252	CcSEcCtD
Tiotropium—Shock—Prednisone—Crohn's disease	0.000154	0.0025	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—Crohn's disease	0.000154	0.00249	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—Crohn's disease	0.000153	0.00248	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—Crohn's disease	0.000152	0.00246	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000143	0.00231	CcSEcCtD
Tiotropium—Insomnia—Prednisone—Crohn's disease	0.000142	0.00229	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—Crohn's disease	0.000141	0.00228	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—Crohn's disease	0.000138	0.00223	CcSEcCtD
Tiotropium—Constipation—Prednisone—Crohn's disease	0.000134	0.00217	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—Crohn's disease	0.000128	0.00207	CcSEcCtD
Tiotropium—Urticaria—Prednisone—Crohn's disease	0.000125	0.00201	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—Crohn's disease	0.000124	0.002	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—Crohn's disease	0.000116	0.00187	CcSEcCtD
Tiotropium—CHRM3—muscle of abdomen—Crohn's disease	0.000113	0.473	CbGeAlD
Tiotropium—Pruritus—Prednisone—Crohn's disease	0.000111	0.00179	CcSEcCtD
Tiotropium—Dizziness—Prednisone—Crohn's disease	0.000104	0.00168	CcSEcCtD
Tiotropium—Vomiting—Prednisone—Crohn's disease	9.98e-05	0.00161	CcSEcCtD
Tiotropium—Rash—Prednisone—Crohn's disease	9.9e-05	0.0016	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—Crohn's disease	9.89e-05	0.0016	CcSEcCtD
Tiotropium—Headache—Prednisone—Crohn's disease	9.84e-05	0.00159	CcSEcCtD
Tiotropium—Nausea—Prednisone—Crohn's disease	9.33e-05	0.00151	CcSEcCtD
Tiotropium—CHRM3—G alpha (q) signalling events—RASGRP1—Crohn's disease	7.62e-05	0.00206	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—CCR6—Crohn's disease	7.55e-05	0.00204	CbGpPWpGaD
Tiotropium—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.53e-05	0.00204	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—GPR65—Crohn's disease	7.46e-05	0.00202	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—GPR65—Crohn's disease	7.44e-05	0.00201	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	7.37e-05	0.00199	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.18e-05	0.00194	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.15e-05	0.00193	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	7.09e-05	0.00192	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.09e-05	0.00191	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.98e-05	0.00189	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.96e-05	0.00188	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.89e-05	0.00186	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	6.84e-05	0.00185	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	6.82e-05	0.00184	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—PTGER4—Crohn's disease	6.65e-05	0.0018	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	6.55e-05	0.00177	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—MLN—Crohn's disease	6.53e-05	0.00176	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	6.46e-05	0.00175	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CCR9—Crohn's disease	6.44e-05	0.00174	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	6.27e-05	0.00169	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ACKR2—Crohn's disease	6.25e-05	0.00169	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	6.19e-05	0.00167	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.15e-05	0.00166	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.13e-05	0.00166	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.07e-05	0.00164	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—GPR65—Crohn's disease	5.99e-05	0.00162	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MLN—Crohn's disease	5.94e-05	0.00161	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MLN—Crohn's disease	5.93e-05	0.0016	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MLN—Crohn's disease	5.87e-05	0.00159	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CCR9—Crohn's disease	5.85e-05	0.00158	CbGpPWpGaD
Tiotropium—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.66e-05	0.00153	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—GPR65—Crohn's disease	5.44e-05	0.00147	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.35e-05	0.00145	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	5.32e-05	0.00144	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	5.3e-05	0.00143	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ACKR2—Crohn's disease	5.26e-05	0.00142	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	5.25e-05	0.00142	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MLN—Crohn's disease	4.99e-05	0.00135	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.96e-05	0.00134	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.73e-05	0.00128	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	4.68e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	4.67e-05	0.00126	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	4.62e-05	0.00125	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	4.56e-05	0.00123	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	4.54e-05	0.00123	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	4.52e-05	0.00122	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	4.48e-05	0.00121	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	4.27e-05	0.00115	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	4.22e-05	0.00114	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	4.21e-05	0.00114	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	4.16e-05	0.00113	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	4.12e-05	0.00111	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	4.11e-05	0.00111	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	4.07e-05	0.0011	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	3.99e-05	0.00108	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.88e-05	0.00105	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	3.88e-05	0.00105	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	3.83e-05	0.00104	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PLA2G4F—Crohn's disease	3.83e-05	0.00103	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	3.83e-05	0.00103	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	3.82e-05	0.00103	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	3.78e-05	0.00102	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	3.78e-05	0.00102	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	3.76e-05	0.00102	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.72e-05	0.00101	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	3.7e-05	0.001	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	3.69e-05	0.000998	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	3.66e-05	0.000988	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MLN—Crohn's disease	3.51e-05	0.000949	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MLN—Crohn's disease	3.5e-05	0.000946	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.49e-05	0.000943	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.48e-05	0.00094	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MLN—Crohn's disease	3.47e-05	0.000937	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCR9—Crohn's disease	3.46e-05	0.000934	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	3.41e-05	0.000922	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.33e-05	0.0009	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.32e-05	0.000897	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTMR3—Crohn's disease	3.26e-05	0.00088	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GPR65—Crohn's disease	3.21e-05	0.000868	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	3.21e-05	0.000868	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	3.2e-05	0.000865	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	3.2e-05	0.000865	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.2e-05	0.000864	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	3.17e-05	0.000857	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	3.1e-05	0.000837	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	3.01e-05	0.000812	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	3e-05	0.00081	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	2.97e-05	0.000802	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL3—Crohn's disease	2.91e-05	0.000785	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.88e-05	0.000777	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	2.81e-05	0.00076	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	2.81e-05	0.000759	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	2.8e-05	0.000756	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	2.79e-05	0.000755	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	2.77e-05	0.000749	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	2.73e-05	0.000737	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	2.72e-05	0.000735	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.7e-05	0.000729	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	2.69e-05	0.000728	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	2.66e-05	0.000719	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	2.65e-05	0.000717	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	2.65e-05	0.000715	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	2.64e-05	0.000713	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	2.63e-05	0.00071	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	2.61e-05	0.000706	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—FADS1—Crohn's disease	2.54e-05	0.000685	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	2.43e-05	0.000658	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR9—Crohn's disease	2.43e-05	0.000658	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR9—Crohn's disease	2.43e-05	0.000656	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.42e-05	0.000655	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	2.4e-05	0.000649	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR9—Crohn's disease	2.4e-05	0.000649	CbGpPWpGaD
Tiotropium—CHRM5—epithelium—Crohn's disease	2.4e-05	0.101	CbGeAlD
Tiotropium—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	2.4e-05	0.000647	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GPX4—Crohn's disease	2.38e-05	0.000642	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	2.37e-05	0.000641	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GCKR—Crohn's disease	2.29e-05	0.00062	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCR6—Crohn's disease	2.29e-05	0.000619	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.29e-05	0.000619	CbGpPWpGaD
Tiotropium—CHRM5—skin of body—Crohn's disease	2.28e-05	0.0958	CbGeAlD
Tiotropium—CHRM1—Signaling Pathways—GPR65—Crohn's disease	2.26e-05	0.000611	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GPR65—Crohn's disease	2.26e-05	0.000609	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	2.25e-05	0.000609	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.25e-05	0.000608	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	2.25e-05	0.000607	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.24e-05	0.000606	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	2.24e-05	0.000606	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GPR65—Crohn's disease	2.23e-05	0.000604	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	2.23e-05	0.000601	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.22e-05	0.0006	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	2.18e-05	0.000589	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.18e-05	0.000589	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	2.17e-05	0.000587	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	2.15e-05	0.000581	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RBX1—Crohn's disease	2.07e-05	0.00056	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL3—Crohn's disease	2.05e-05	0.000553	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL3—Crohn's disease	2.04e-05	0.000551	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	2.04e-05	0.00055	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL3—Crohn's disease	2.02e-05	0.000546	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	2.02e-05	0.000545	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	1.98e-05	0.000535	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	1.97e-05	0.000533	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	1.95e-05	0.000528	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.95e-05	0.000526	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	1.82e-05	0.000491	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	1.8e-05	0.000487	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	1.76e-05	0.000476	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL3—Crohn's disease	1.72e-05	0.000464	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	1.71e-05	0.000463	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	1.71e-05	0.000462	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.71e-05	0.000461	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.7e-05	0.00046	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	1.69e-05	0.000457	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	1.66e-05	0.000449	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR6—Crohn's disease	1.61e-05	0.000436	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR6—Crohn's disease	1.61e-05	0.000434	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR6—Crohn's disease	1.59e-05	0.00043	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	1.58e-05	0.000427	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	1.57e-05	0.000425	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	1.56e-05	0.000421	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—FADS1—Crohn's disease	1.52e-05	0.00041	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	1.51e-05	0.000407	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	1.5e-05	0.000407	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.5e-05	0.000404	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RBX1—Crohn's disease	1.46e-05	0.000394	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RBX1—Crohn's disease	1.45e-05	0.000393	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RBX1—Crohn's disease	1.44e-05	0.000389	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	1.43e-05	0.000388	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	1.43e-05	0.000387	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	1.43e-05	0.000386	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX4—Crohn's disease	1.42e-05	0.000384	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	1.42e-05	0.000384	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	1.42e-05	0.000382	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	1.42e-05	0.000382	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	1.4e-05	0.000379	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	1.38e-05	0.000372	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GCKR—Crohn's disease	1.37e-05	0.000371	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	1.37e-05	0.00037	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	1.3e-05	0.000351	CbGpPWpGaD
Tiotropium—CHRM3—smooth muscle tissue—Crohn's disease	1.29e-05	0.0543	CbGeAlD
Tiotropium—SLC22A4—digestive system—Crohn's disease	1.29e-05	0.0543	CbGeAlD
Tiotropium—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	1.28e-05	0.000345	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	1.27e-05	0.000344	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.27e-05	0.000344	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	1.26e-05	0.000341	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	1.25e-05	0.000338	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	1.24e-05	0.000335	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	1.24e-05	0.000334	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	1.22e-05	0.000331	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL3—Crohn's disease	1.21e-05	0.000327	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL3—Crohn's disease	1.21e-05	0.000326	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	1.2e-05	0.000325	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL3—Crohn's disease	1.19e-05	0.000322	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	1.17e-05	0.000316	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	1.17e-05	0.000315	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	1.15e-05	0.000312	CbGpPWpGaD
Tiotropium—SLC22A5—skin of body—Crohn's disease	1.07e-05	0.0449	CbGeAlD
Tiotropium—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.06e-05	0.000287	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	1.06e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	1.06e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	1.06e-05	0.000285	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	1.05e-05	0.000283	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	1.05e-05	0.000283	CbGpPWpGaD
Tiotropium—CHRM3—digestive system—Crohn's disease	1.02e-05	0.0429	CbGeAlD
Tiotropium—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	1.01e-05	0.000273	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	1.01e-05	0.000272	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	9.97e-06	0.000269	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—FADS1—Crohn's disease	9.92e-06	0.000268	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	9.69e-06	0.000262	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	9.66e-06	0.000261	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	9.64e-06	0.00026	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	9.61e-06	0.00026	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	9.56e-06	0.000258	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	9.51e-06	0.000257	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX4—Crohn's disease	9.28e-06	0.000251	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	9.15e-06	0.000247	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	9.12e-06	0.000246	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	9.03e-06	0.000244	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCKR—Crohn's disease	8.97e-06	0.000242	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	8.8e-06	0.000238	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	8.77e-06	0.000237	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	8.68e-06	0.000235	CbGpPWpGaD
Tiotropium—SLC22A5—digestive system—Crohn's disease	8.54e-06	0.0359	CbGeAlD
Tiotropium—CHRM5—Signaling Pathways—TYK2—Crohn's disease	8.48e-06	0.000229	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	8.47e-06	0.000229	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	8.44e-06	0.000228	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	8.36e-06	0.000226	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—JAK2—Crohn's disease	8.09e-06	0.000218	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	7.38e-06	0.000199	CbGpPWpGaD
Tiotropium—SLC22A4—lymph node—Crohn's disease	7.37e-06	0.031	CbGeAlD
Tiotropium—CHRM3—Metabolism—ALB—Crohn's disease	7.3e-06	0.000197	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—Crohn's disease	7.02e-06	0.00019	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—Crohn's disease	6.39e-06	0.000173	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TYK2—Crohn's disease	5.97e-06	0.000161	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TYK2—Crohn's disease	5.95e-06	0.000161	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STAT3—Crohn's disease	5.93e-06	0.00016	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TYK2—Crohn's disease	5.89e-06	0.000159	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JAK2—Crohn's disease	5.69e-06	0.000154	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JAK2—Crohn's disease	5.68e-06	0.000153	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JAK2—Crohn's disease	5.62e-06	0.000152	CbGpPWpGaD
Tiotropium—CYP3A4—digestive system—Crohn's disease	5.6e-06	0.0236	CbGeAlD
Tiotropium—CYP2D6—digestive system—Crohn's disease	5.51e-06	0.0232	CbGeAlD
Tiotropium—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	5.2e-06	0.00014	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	5.18e-06	0.00014	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	5.13e-06	0.000139	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—Crohn's disease	4.94e-06	0.000133	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—Crohn's disease	4.93e-06	0.000133	CbGpPWpGaD
Tiotropium—SLC22A5—lymph node—Crohn's disease	4.88e-06	0.0205	CbGeAlD
Tiotropium—CHRM2—Signaling by GPCR—IL6—Crohn's disease	4.88e-06	0.000132	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—Crohn's disease	4.37e-06	0.000118	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STAT3—Crohn's disease	4.18e-06	0.000113	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STAT3—Crohn's disease	4.17e-06	0.000113	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—Crohn's disease	4.15e-06	0.000112	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STAT3—Crohn's disease	4.12e-06	0.000111	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.82e-06	0.000103	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.92e-06	7.89e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—Crohn's disease	2.91e-06	7.86e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.88e-06	7.78e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—Crohn's disease	2.85e-06	7.71e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.5e-06	6.75e-05	CbGpPWpGaD
